×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  

The Diabetes and Obesity Market Opportunity

July 6, 2023

 

Health care analysts Marshall Gordon and Brittany Henderson join Jeff Schulze to highlight new treatments for the chronic conditions of diabetes and obesity. They quantify the size of the Type 1 and Type 2 diabetes and obesity markets, discuss innovations in managing diabetes and explain how GLP-1 therapeutics developed to treat diabetes can be effective in addressing the much larger obese population.

Related Perspectives

Large Cap Growth Monthly Update
Large Cap Growth April 2026: A risk-on April provided a measure of confidence in the Strategy’s ability to participate effectively in strong up markets.
Panning for Fresh Sources of Growth
International Growth EAFE 1Q26: We see a better setup for the Strategy as growth’s valuation premium narrows and we reposition into newer areas of growth outside technology.
Resetting as Growth Becomes More Attractive
International Growth ADR 1Q26: We remain optimistic about the outlook for growth stocks and believe the Strategy is well placed for improved outcomes going forward.
Stabilizing Growth Setup Through Volatility
Large Cap Growth 1Q26: The Strategy outperformed in a risk-off quarter, supported by diversified contributions outside of mega cap technology.
Embracing the Semiconductor Super Cycle
Podcast: Analyst Dalya Hahn provides an overview of the semiconductor industry and where she sees AI and supply driven opportunities.
More
  • Past performance is no guarantee of future results. Copyright © 2023 ClearBridge Investments. All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information.

more